NGNE — Neurogene Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Neurogene, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	143	193	142	96.4	197
Net Total Accounts Receivable
Net Total Receivables	0.503	0.9	—	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	144	195	144	99.1	200
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.83	13.7	17.2	15.9	21
Net Intangible Assets
Other Long Term Assets
Total Assets	147	211	163	116	223
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4.74	7.89	8.64	11.1	23
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	5.34	19.3	20.4	21.6	36.5
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	142	191	143	94.3	186
Total Liabilities & Shareholders' Equity	147	211	163	116	223
Total Common Shares Outstanding